Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Apr;84(1):103-8.

Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states

Affiliations

Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states

E N Sarno et al. Clin Exp Immunol. 1991 Apr.

Abstract

The possible role of cytokines in leprosy reactions was investigated by analysing the levels of tumour necrosis factor (TNF) and interleukin-1 (IL-1) in serum samples from 39 leprosy patients, 22 of them presenting either type I (upgrading) or type II (ENL) reactions. Fifty per cent of the patients showed elevated concentrations of TNF and IL-1 in at least one of the serum samples tested. This included all four patients undergoing type I reversal reaction and nine (50%) of the ENL patients studied. Concentrations of TNF above 1000 pg/ml were found in four patients with ENL. Development of erythema multiforme in these ENL patients represented an aggravating factor and all four patients suffering from this type of lesion demonstrated increased serum TNF levels. All BT patients tested presented elevated IL-1 levels, while only half of them presented elevated levels of TNF. No correlation was found between any particular systemic symptoms and the levels of TNF and IL-1. These results suggest that TNF and IL-1 may be implicated in leprosy reactions, either acting directly or in synergism with other cytokines.

PubMed Disclaimer

References

    1. Br Med Bull. 1987 Apr;43(2):350-70 - PubMed
    1. Int J Lepr Other Mycobact Dis. 1987 Mar;55(1):36-41 - PubMed
    1. J Leukoc Biol. 1988 May;43(5):429-35 - PubMed
    1. Cell. 1988 Jul 15;54(2):141-2 - PubMed
    1. Int J Dermatol. 1987 Jun;26(5):278-85 - PubMed

Publication types

MeSH terms